GHRS
GH Research Plc
NASDAQ · Healthcare · Biotechnology · IE
$18.28
+0.72%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.49x
- Price / sales
- —
- Price / cash flow
- -23.95x
Enterprise value
- Enterprise value
- $892.5M
- EV / sales
- —
- EV / EBITDA
- -14.46x
- EV / EBIT
- -12.49x
- Market cap
- $1.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026